Displaying drugs 276 - 300 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Urofollitropin | 980.162 C42H65N11O12S2 |  | A form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure. | Gonadotropins |
| Eptifibatide | 831.962 C35H49N11O9S2 |  | A peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention. | Platelet Aggregation Inhibitors Excl. Heparin |
| Thyroglobulin | 660.0 |  | For the treatment of hypothyroidism (deficiency in the production of thyroid hormone). | Globulins / Glycoproteins / Iodoproteins |
| Antihemophilic factor (recombinant), PEGylated | 284.0 | | For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... | Recombinant Proteins |
| Damoctocog alfa pegol | 234.0 | | A recombinant Factor VIII used to treat hemophilia A to control bleeding, perioperative bleeding, and also for prophylaxis of bleeding. | Blood Coagulation Factors / Pegylated agents |
| Guselkumab | 143.6 C6402H9864N1676O1994S42 | | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
| Cerliponase alfa | 59.0 | | An enzyme replacement therapy used to treat neuronal ceroid lipofuscinosis type 2 (CLN2) disease, also known as tripeptidyl peptidase 1 (TPP1) deficiency. | Enzymes / Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase |
| Anti-inhibitor coagulant complex | Not Available | | A medication used to control bleeding episodes and prevent bleeding episodes in hemophilia A and B. | Blood Coagulation Factors |
| Coagulation factor VII human | Not Available | | A coagulation factor used to treat bleeding disorders such as hemophilia and Glanzmann's thrombasthenia. | Blood Coagulation Factors / Enzyme Precursors |
| Catridecacog | Not Available |  | A recombinant FXIII subunit‐A molecule evaluated for clotting factor replacement therapy in congenital FXIII deficiency. | Blood Coagulation Factors |
| Factor IX Complex (Human) | Not Available | | A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. | Blood Coagulation Factors / Enzyme Precursors / Factor IX |
| Fibrinogen human | Not Available | | A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. | Fibrinogen |
| Human thrombin | Not Available |  | A platelet activating factor used to treat minor bleeding. | Blood Coagulation Factors |
| Protamine sulfate | Not Available | | A blood factor used when the reversal of the anticoagulant effect of heparin is necessary and for the treatment of heparin overdose. | Heparin Antagonists / Heparin Reversal Agent / Nuclear Proteins / Nucleoproteins |
| Protein C | Not Available |  | A medication used to treat protein C deficiency leading to purpura fulminans or coumarin-induced skin necrosis. | Enzymes |
| Prothrombin | Not Available | | A coagulation factor used for emergency reversal of vitamin K antagonist therapy. | Blood Coagulation Factors / Enzyme Precursors / Prothrombin, agonists |
| Thrombin alfa | Not Available |  | A platelet activating factor used to treat minor bleeding. | Blood Coagulation Factors / Hemorrhage / Hemostatics |
| Hemin | Not Available | | An iron-containing porphyrin injection used for the relief of recurrent attacks of acute intermittent porphyria (AIP) associated with the menstrual cycle when carbohydrate therapy is not effective. | Heme products |
| Plasma protein fraction (human) | Not Available | | A plasma protein solution used to treat coagulation factor deficiencies, reverse anticoagulant effects, and shock from a loss of plasma fluids, and is also used in plasma exchange procedures. | Plasma Substitutes |
| Factor XIII (human) | Not Available | | A purified form of Factor XIII that is used to prevent and treat surgical bleeding in patients with a Factor XIII deficiency. | Blood Coagulation Factors / Enzyme Precursors / Factor XIIIa, antagonists & inhibitors / Transglutaminases |
| Thrombin | Not Available |  | A coagulation factor used to stop bleeding during surgery. | Local Hemostatics |
| Beroctocog alfa | Not Annotated | | Beroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in... | Blood Coagulation Factors / Coagulants / Factor VIII / Human Antihemophilic Factors / Protein Precursors |
| Andexanet alfa | Not Available | | A recombinant Factor Xa used to reverse anticoagulation caused by rivaroxaban and apixaban. | Antidotes |
| Turoctocog alfa pegol | Not Available | | Turoctocog alfa pegol is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to... | Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Factor VIII / Hemostatics / Proteins / Recombinant Proteins |
| Hemoglobin | Not Annotated | | An iron-containing protein found in all red blood cells (RBCs) for proper binding of oxygen and transport throughout the body, included in blood transfusions in severe hemorrhage. | Blood Proteins / Globins / Hemoglobins |
Displaying drugs 276 - 300 of 406 in total